About
73.71USD+0.79 +1.08%
Closed • Updated at 13:10 GMT+00:00Market Cap$4.05B
P/E Ratio38.05
Volume712.0K
Beta1.90
RSI64.85
Gross Margin67.56%
Livanova Plc — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
Apr 20 2026
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
Mar 25 2026
LivaNova to Announce First-Quarter 2026 Results
Mar 19 2026
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
Feb 25 2026
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
Google Übersetzer